What began as severe lower back pain for Teona Ducre led to a diagnosis of Stage III pancreatic cancer at age 41. She underwent surgery to remove a tumor, but that was preceded by an aggressive chemotherapy regimen, first six months with folfirinox, supplemented by xeloda and gemzar abraxane. Teona went through the terrible side effects associated with chemotherapy, but doctors determined she was in remission and fully cancer-free.
In March 2016, Teona Ducre of Atlanta, Georgia began to experience lower back pain. In addition, there was nausea. When she sought medical attention, she probably had acid reflux, perhaps irritable bowel syndrome. When she became sick and had the chills, she went back to a doctor, who ordered a CT scan. It revealed a large mass on her pancreas and on April Fool’s Day, she was told she could have cancer.
Teona went before another group of doctors who looked at the same scan and immediately said that she has Stage III pancreatic cancer, inoperable adenocarcinoma. The decision was made to have a chance to remove the tumor, she would need to go on chemotherapy in an attempt to shrink the tumor. If that was successful, then they would try surgery in about six months. Ultimately this plan worked, but in 2016, the prospect of chemo before surgery was not the standard of care. However, the care team had data that suggested it was better to first shrink the tumor and then operate.
Teona’s chemotherapy experience included getting a port in her chest, hair loss, her losing weight when eating became unpleasant as food tasted like metal. All this was a result of her going on six months of folfirinox, a platinum-based chemotherapy. She did 12 rounds and her white blood cells had dropped so low she had to take a break before resuming. The chemotherapy regimen did what it was supposed to do, it shrunk the tumor and doctors were able to successfully remove what was left of the tumor.
Ironically, after once being diagnosed with inoperable adenocarcinoma, she went in for her first post-treatment checkup, and her oncologist didn’t know what to do. That was because so few people diagnosed with Stage III pancreatic cancer don’t make it as far as she did.
The oncologist wanted to be safe and put Teona on a regimen of an oral chemotherapy, gemzar abraxane and xeloda. Once that regimen was complete, the oncologist said Teona Ducre was in remission and cancer-free. She still was not 100 percent, but had to go back to work because if she didn’t, her employer would have to discontinue her health benefits. She split the difference and returned to work part-time as she was still feeling some fatigue.
Teona Ducre has been cancer-free since November 2016. With part of her pancreas gone, she still goes in for periodic checkups to check her blood sugar levels to make sure no tumors have developed and that she doesn’t develop diabetes.
Additional Resources:
Support Group:
Pancreatic Cancer Action Network
https://www.pancan.org
Purple Pansies
https://purplepansies.org
Piedmont Oncology Andrew Page Pancreas Cancer Foundation
https://piedmont.org/cancer/pancreatic-and-liver/andrew-page-pancreas-cancer-fund